If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Corporate Update

14 Sep 2009 07:00

RNS Number : 9502Y
Tarsus Group PLC
14 September 2009
 



14 September 2009

Tarsus Group plc

Corporate Update

Tarsus Group plc ('Tarsus' or 'the Group' or 'the Company'), the international business-to-business media group, is pleased to announce the following corporate update for the period since the announcement of its record interim results on 29th July 2009..

France

The Group has disposed of its 50% shareholding in MD Management SAS to its joint venture partner, Reed Exhibitions France, for a net cash consideration of £ 0.4 million. 

This transaction has resulted in a small book profit and continues the strategy of rationalising the Group's portfolio to focus on larger events, with established brands, which tend to be more resilient throughout the economic cycle.

China

Tarsus has entered into an agreement with its joint venture partner Hubei Hope to invest together a further RMB 10 million (approximately £ 0.9 million) of cash into their joint venture, Tarsus Hope.

The monies will be used to fund acquisitions and new launches in the joint venture's core exhibition sectors of medical equipment and industrial equipment in Central China. The investment is conditional on Chinese regulatory approval, but marks a further step in the development of the Group's portfolio of events in one of the fastest growing exhibition markets in the world.

Trading

The Group's second half exhibitions have begun well, with the Off-Price Show in Las Vegas in August and the Medical event in San Jose in September both now currently trading slightly ahead of management's previous expectations.

Importantly, revenues for the two largest exhibitions in Tarsus' portfolio, Labelexpo Europe in September and the Dubai Airshow in November, continue to remain comfortably ahead of the comparable events in 2007. 

Douglas Emslie, Group Managing Director, said:

"We continue to execute against our strategy of increasing our business in the faster growing emerging markets while actively managing our portfolio in our mature markets.

 Trading for the Group for the full year continues to be in line with the Board's expectations and we anticipate a very satisfactory outcome for 2009."

For further information please contact:

Tarsus Group plc

Douglas Emslie, Group Managing Director 020 8846 2700

Ashley Milton, Group Finance Director 020 8846 2700

Media

Matthew Moth, Madano Partnership 020 7593 4000

Investor Relations

Neville Harris, IR Focus 020 7593 4015

Stephen ScottJeremy Wiseman, Scott Harris 020 7653 0030

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLBMITMMTBBLL
Date   Source Headline
8th Dec 20164:35 pmRNSHolding(s) in Company
8th Dec 20164:33 pmRNSHolding(s) in Company
8th Dec 20164:31 pmRNSHolding(s) in Company
8th Dec 20164:29 pmRNSHolding(s) in Company
8th Dec 20167:00 amRNSCompletion of Acquisition
7th Dec 20169:00 amRNSAdmission of Placing Shares
5th Dec 201612:30 pmRNSCompletion of Placing
5th Dec 20167:00 amRNSProposed Placing and Acquisition
1st Dec 201610:46 amRNSTotal Voting Rights
22nd Nov 20167:00 amRNSCapital Markets Event and Trading Update
9th Nov 20163:19 pmRNSBlock listing Interim Review
31st Oct 20169:52 amRNSTotal Voting Rights
13th Oct 20167:24 amRNSDirector/PDMR Shareholding
12th Oct 20167:00 amRNSTrading Update
30th Sep 20169:53 amRNSTotal Voting Rights and Capital
1st Sep 201612:09 pmRNSTotal Voting Rights
15th Aug 20165:28 pmRNSInterim financial statements
9th Aug 20166:11 pmRNSHolding(s) in Company
29th Jul 201612:10 pmRNSTotal Voting Rights and Capital
27th Jul 20167:00 amRNSHalf-year Report
11th Jul 20161:30 pmRNSApplication for Admission
5th Jul 20161:12 pmRNSHolding(s) in Company
30th Jun 201612:28 pmRNSTotal Voting Rights
21st Jun 20164:42 pmRNSDirector/PDMR Shareholding
20th Jun 20164:00 pmRNSResult of AGM
7th Jun 20161:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:58 pmRNSScrip Dividend Circular (the "Circular")
31st May 201611:59 amRNSTotal Voting Rights and Capital
17th May 20163:08 pmRNSNotice of 2016 Annual General Meeting
17th May 20167:00 amRNSTrading Update
11th May 20167:00 amRNSDirector/PDMR Shareholding
9th May 20163:43 pmRNSBlock Listing Six Monthly Return
29th Apr 20164:14 pmRNSTotal Voting Rights
31st Mar 20162:25 pmRNSTotal Voting Rights
31st Mar 20162:24 pmRNSDirector/PDMR Shareholding
21st Mar 20163:11 pmRNS2015 Annual Report
8th Mar 20165:55 pmRNSDirector/PDMR Shareholding
3rd Mar 20164:47 pmRNSDirector/PDMR Shareholding
2nd Mar 20167:00 amRNSFinal Results
2nd Feb 20163:48 pmRNSTotal Voting Rights and Capital
25th Jan 20161:05 pmRNSApplication for Admission
12th Jan 20167:00 amRNSYear-end trading update
31st Dec 20159:25 amRNSTotal Voting Rights
14th Dec 20155:07 pmRNSScrip dividend circular
8th Dec 20157:00 amRNSCapital markets presentation
2nd Dec 20153:49 pmRNSDirector/PDMR Shareholding
30th Nov 20154:35 pmRNSTotal Voting Rights
11th Nov 201510:00 amRNSBlock Listing Six Monthly Return
30th Oct 20153:22 pmRNSDirector/PDMR Shareholding
30th Oct 20153:20 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.